Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Blue Apron Will Have Trouble Keeping Its Newfound Customers

By Will Ashworth, InvestorPlace Contributor
On one hand, Blue Apron benefits from a hostage audience willing to try its services. But once the pandemic fades, the case for Blue Apron stock will quickly nosedive.

Smokers’ Susceptibility to the Coronavirus Will Hurt CGC Stock

By Larry Ramer, InvestorPlace Contributor
The fact that smoking is a key risk factor for dying from coroavirus will hurt CGC stock. The company is facing other difficulties as well.

As Warren Buffett Sells DAL Stock, It May Be Time to Bail Yourself

By Tezcan Gecgil, InvestorPlace Contributor
Unless we have more clarity as to when our economy will be back at normal capacity, investors in DAL stock should be ready for more turbulence in the coming weeks.

Don’t Buy Into American Airlines’ Redemption Story Here

By Todd Shriber, InvestorPlace Contributor
From 2014 through 2019, American spent nearly $13 billion combined on buybacks and dividends, yet here we are discussing a stock that trades at a third of the levels it did in early 2014 and is flirting with all time lows.

At $130, Spotify Stock Is Fully-Valued For the Rest of the Year

By Luke Lango, InvestorPlace Senior Investment Analyst
Investors should beware overconfidence in coronavirus-resistant SPOT stock, given it currently trades around the 2020 price target.

Alpha Pro Tech Is a One-Trick Pony

By InvestorPlace Research Staff
While APT stock may appear to be supported by a very pertinent business, historically, Alpha Pro Tech has been a one-catalyst show. And once that catalyst fades, so too does the stock.

Inovio Stock Isn’t A Coronavirus Bet Worth Buying Into

By Marie Brodbeck, InvestorPlace Contributor
Although Inovio has the potential to explode higher on a coronavirus vaccine, the firm's hefty debt pile and lack of other catalysts makes it too risky to buy right now.

The Best Buy Opportunity in Lakeland Industries Stock Is Long Gone

By InvestorPlace Research Staff
With tremendous demand for protective equipment, Lakeland Industries stock has surged to prominence. Still, the longer-term outlook is questionable now that Covid-19 cases are mathematically decelerating.

Don’t Roll the Dice on CZR Stock

By Josh Enomoto, InvestorPlace Contributor
Although the discount in CZR stock may look attractive to some, the contrarian bet is too risky because of economic and societal unknowns.

Why Virgin Galactic Could Keep Falling as Investor Unease Increases

By Chris Lau, InvestorPlace Contributor
SPCE stock faces selling pressure as revenue bookings may not translate to sales in 2021. Put Virgin Galatic on the future "maybe" list.

Even with a Saudi-Russian Deal, Exxon Mobil Stock Is Risky

By Josh Enomoto, InvestorPlace Contributor
Undoubtedly, a deal between Saudi Arabia and Russia would do much to lift Exxon Mobil stock in the near term. But the bigger problem is that without a viable global economy, XOM still faces severe risks.

Chesapeake Energy Stock Will Not Survive 2020

By Ian Cooper, InvestorPlace Contributor
Chesapeake Energy is staring down the barrel of a reverse stock split, and the future for CHK stock doesn't look any brighter.

Carnival Cruise Stock Has Never Faced a Disaster Like Coronavirus

By Brad Moon, InvestorPlace Contributor
CCL stock is down 75% this year as coronavirus hammers the cruise industry, but will Carnival recover from this latest nautical disaster?

7 Failing Tech Stocks to Disconnect From Now

By Louis Navellier, Editor, Growth Investor
Disconnect from these failing tech stocks now before they drag you down. These companies just can't keep up with today's tech trends.

It’s Definitely Time to Unload Zoom Stock While You Can

By Larry Ramer, InvestorPlace Contributor
The likely earlier than expected end to the coronavirus crisis and security issues are among the factors that will push down Zoom stock.

If You’re Looking for Income, BP Stock Is Not the Answer

By Will Ashworth, InvestorPlace Contributor
BP is currently yielding 9.9%. If you’re looking to generate some short-term income with BP stock, you’re wise to look elsewhere in 2020.  

AIM Stock Is a Moonshot That Lacks the Fuel

By Chris Markoch, InvestorPlace Contributor
Though AIM stock is relevant on paper, with competition raging in the race for a coronavirus treatment, along with AIM ImmunoTech's checkered past, this is a very speculative gamble.

When It Comes to Coronavirus Investing, CODX Stock Is a Bad Bet

By Ian Bezek, InvestorPlace Contributor
Many companies are vying to deliver the best coronavirus test. Co-Diagnostics is unlikely to be the ultimate winner in a crowded marketplace.

WMT Stock Looks Weak as the Coronavirus Subsides

By Larry Ramer, InvestorPlace Contributor
The high valuation of WMT stock and the likely declines of its sales growth next month make the shares unattractive at this point.
Load More Articles